Circulating tumor HPV DNA in the management of HPV+ oropharyngeal cancer and its correlation with MRI.
Flaminia CampoFrancesca PaoliniValentina MancioccoSilvia MorettoBarbara PichiClaudio MorettiGiovanni BlandinoValentina De PascaleMaria BenevoloFulvia PimpinelliAntonello VidiriSimona MarziSergio RuggieroIrene TerrenatoOreste IoccaAldo VenutiRaul PelliniPublished in: Head & neck (2024)
ctHPVDNA was superior to p16 in identification of HPV-OPSCC at diagnosis. Introduction of ctHPVDNA, beyond diagnostic setting, represents a great opportunity to improve follow-up protocol of OPSCC patients.
Keyphrases
- circulating tumor
- high grade
- end stage renal disease
- cell free
- circulating tumor cells
- ejection fraction
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- magnetic resonance imaging
- peritoneal dialysis
- papillary thyroid
- prognostic factors
- cervical cancer screening
- single molecule
- magnetic resonance
- patient reported outcomes